InvestorsHub Logo
Followers 79
Posts 24513
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Thursday, 06/22/2017 8:51:51 AM

Thursday, June 22, 2017 8:51:51 AM

Post# of 27420
DMPI - 1.85 Pre-market at 2.00/2.11

DelMar Pharmaceuticals Receives Institutional Review Board Approval for Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.